Literature DB >> 34424034

Metabolism of Poly-β1,4-N-Acetylglucosamine Substrates and Importation of N-Acetylglucosamine and Glucosamine by Enterococcus faecalis.

Erica C Keffeler1, Srivatsan Parthasarathy1, Zakria H Abdullahi1, Lynn E Hancock1.   

Abstract

The ability of Enterococcus faecalis to use a variety of carbon sources enables colonization at various anatomic sites within a mammalian host. N-Acetylglucosamine (GlcNAc) is one of the most abundant natural sugars and provides bacteria with a source of carbon and nitrogen when metabolized. N-Acetylglucosamine is also a component of bacterial peptidoglycan, further highlighting the significance of N-acetylglucosamine utilization. In this study, we show that CcpA-regulated enzymes are required for growth on the poly-β1,4-linked GlcNAc substrate, chitopentaose (β1,4-linked GlcNAc5). We also show that EF0114 (EndoE) is required for growth on chitobiose (β1,4-linked GlcNAc2) and that the GH20 domain of EndoE is required for the conversion of GlcNAc2 to N-acetylglucosamine. GlcNAc is transported into the cell via two separate phosphotransferase system (PTS) complexes, either the PTS IICBA encoded by ef1516 (nagE) or the Mpt glucose/mannose permease complex (MptBACD). The Mpt PTS is also the primary glucosamine transporter. In order for N-acetylglucosamine to be utilized as a carbon source, phosphorylated N-acetylglucosamine (GlcNAc-6-P) must be deacetylated, and here, we show that this activity is mediated by EF1317 (an N-acetylglucosamine-6-phosphate deacetylase; NagA homolog), as a deletion of ef1317 is unable to grow on GlcNAc as the carbon source. Deamination of glucosamine to fructose-6-phosphate is required for entry into glycolysis, and we show that growth on glucosamine is dependent on EF0466 (a glucosamine-6-phosphate deaminase; NagB homolog). Collectively, our data highlight the chitinolytic machinery required for breaking down exogenous chitinous substrates, as well as the uptake and cytosolic enzymes needed for metabolizing N-acetylglucosamine. IMPORTANCE Enterococcus faecalis causes life-threatening health care-associated infections in part due to its intrinsic and acquired antibiotic resistance, its ability to form biofilms, and its nutrient versatility. Alternative nutrient acquisition systems are key factors that contribute to enterococcal colonization at biologically unique host anatomic sites. Although E. faecalis can metabolize an array of carbon sources, little is known of how this bacterium acquires these secondary nutrient sources in mammalian hosts. Our research identifies the glycosidase machinery required for degrading exogenous chitinous substrates into N-acetylglucosamine monomers for transport and metabolism of one of the most abundant naturally occurring sugars, N-acetylglucosamine. Disrupting the function of this N-acetylglucosamine acquisition pathway may lead to new treatments against multidrug-resistant enterococcal infections.

Entities:  

Keywords:  CcpA; Enterococcus faecalis; GH18 family; GH20 family; N-acetylglucosamine, GlcNAc; chitin; glycosyl hydrolase; metabolism

Mesh:

Substances:

Year:  2021        PMID: 34424034      PMCID: PMC8508097          DOI: 10.1128/JB.00371-21

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  63 in total

1.  Structural basis for the substrate specificity of a novel β-N-acetylhexosaminidase StrH protein from Streptococcus pneumoniae R6.

Authors:  Yong-Liang Jiang; Wei-Li Yu; Jun-Wei Zhang; Cecile Frolet; Anne-Marie Di Guilmi; Cong-Zhao Zhou; Thierry Vernet; Yuxing Chen
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

2.  Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung.

Authors:  Sruti DebRoy; Jenny Dao; Maria Söderberg; Ombeline Rossier; Nicholas P Cianciotto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

Review 3.  Nutrition and health of edible insects.

Authors:  Arnold van Huis
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2020-05       Impact factor: 4.294

Review 4.  CcpA-dependent carbon catabolite repression in bacteria.

Authors:  Jessica B Warner; Juke S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

5.  Comparative genomic analysis of pathogenic and probiotic Enterococcus faecalis isolates, and their transcriptional responses to growth in human urine.

Authors:  Heidi C Vebø; Margrete Solheim; Lars Snipen; Ingolf F Nes; Dag A Brede
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

6.  The transcriptome of the nosocomial pathogen Enterococcus faecalis V583 reveals adaptive responses to growth in blood.

Authors:  Heidi C Vebø; Lars Snipen; Ingolf F Nes; Dag A Brede
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

7.  Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion.

Authors:  Lance R Thurlow; Vinai Chittezham Thomas; Sherry D Fleming; Lynn E Hancock
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

8.  Activity of CcpA-Regulated GH18 Family Glycosyl Hydrolases That Contributes to Nutrient Acquisition and Fitness in Enterococcus faecalis.

Authors:  Erica C Keffeler; Vijayalakshmi S Iyer; Andrew J Henderson; Ian L Huck; Nancy Schwarting; Analaura Cortez; Lynn E Hancock
Journal:  Infect Immun       Date:  2021-08-23       Impact factor: 3.441

9.  Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains.

Authors:  Michael S Gilmore; Marcus Rauch; Matthew M Ramsey; Paul R Himes; Sriram Varahan; Janet M Manson; Francois Lebreton; Lynn Ernest Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

10.  Data, information, knowledge and principle: back to metabolism in KEGG.

Authors:  Minoru Kanehisa; Susumu Goto; Yoko Sato; Masayuki Kawashima; Miho Furumichi; Mao Tanabe
Journal:  Nucleic Acids Res       Date:  2013-11-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.